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Edited by Veli-Pekka LehtoAbstract The objective of this study was to identify proteins
modiﬁed with O-linked N-acetylglucosamine (O-GlcNAc) in
pancreatic b-cells and to understand their roles in cell death un-
der hyperglycemic conditions. Here we report that heat shock
protein 60 (HSP60) is modiﬁed with O-GlcNAc. Levels of
O-GlcNAcylated HSP60 increased twofold in response to hyper-
glycemic conditions. HSP60 is a chaperonin known to bind to
Bax in the cytoplasm under normoglycemic conditions. Under
hyperglycemic conditions, Bax detached from O-GlcNAcylated
HSP60 and translocated to mitochondria. Hyperglycemic condi-
tions were also associated with cytochrome c release, caspase-3
activation, and cell death, suggesting that elevated O-GlcNAcy-
lation of HSP60 interferes with HSP60–Bax interactions, lead-
ing to pancreatic b-cell death.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cell death1. Introduction
Progression of type-2 diabetes is marked by the inability of
b-cells to produce suﬃcient amounts of insulin to control
blood glucose levels, causing patients to become increasingly
hyperglycemic [1]. It has been suggested that prolonged hyper-
glycemia (HG) may cause damage to b-cells [2]. However, the
exact mechanism(s) by which high glucose concentrations
aﬀect b-cells remains unknown.
The hexosamine biosynthetic pathway is one of the possible
mechanisms by which HG mediates its deleterious eﬀects [3].
In this pathway, UDP-N-acetylglucosamine (UDP-GlcNAc),
generated by glutamine:fructose-6-phosphate amidotransfer-
ase, serves as a substrate for the modiﬁcation of intracellularAbbreviations: HSP, heat shock protein; O-GlcNAc, O-linked N-ace-
tylglucosamine; OGT, O-GlcNAc transferase; O-GlcNAcase, N-acetyl-
glucosaminidase; HG, hyperglycemia; NG, normoglycemia; Mito,
mitochondrial fraction; Cyto, cytosolic fraction; Cyto c, cytochrome c
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doi:10.1016/j.febslet.2006.03.043proteins with O-linked N-acetylglucosamine (O-GlcNAc) at
serine/threonine residues [4,5]. O-GlcNAcylation, a dynamic
and reversible process regulated by O-GlcNAc transferase
(OGT) and N-acetylglucosaminidase (O-GlcNAcase), may
play a role in certain diseases such as Parkinson’s disease, Alz-
heimer’s disease, and diabetes [6–8]. In patients with diabetes,
HG leads to apoptotic cell death and elevated and/or altered
expression of O-GlcNAcylated proteins in various cell types
[9–11]. O-GlcNAcylation appears to modulate transcription
and translation, nuclear targeting and transport, protein sta-
bility, and protein interactions [11,12]. However, the function
of proteins modiﬁed with O-GlcNAc during HG is not fully
understood.
Here we demonstrate that heat shock protein 60 (HSP60) is
O-GlcNAcylated, and its modiﬁcation is markedly enhanced
by treatment with 50 mM glucose. Additionally, Bax is re-
leased from hyperglycosylated HSP60 and translocates to
mitochondria, triggering cytochrome c (Cyto c) release and
caspase-3 activation. Our results suggest that alterations in
the O-GlcNAcylation status of HSP60 in response to HG
may aﬀect the pancreatic b-cell death by regulating interac-
tions between HSP60 and Bax.2. Materials and methods
2.1. Cell culture
Cultures of Rin-m5f cells, a rat pancreatic b-cell line, were grown in
monolayer in DMEMsupplemented with 10%FBS, 1% penicillin/strep-
tomycin, 3.7 g/L NaHCO3, and 5 mM glucose in 5% CO2/95% air at
37 C. HG was induced by addition of glucose (10–50 mM).
2.2. Cell viability test
Cell viability was measured by the 3-[4,5-dimethylthiazol-2-yl]-2,5-di-
phenyl tetrazolium bromide (MTT) assay. Brieﬂy, cells were cultured in
medium supplemented with 5 mM or 50 mM glucose in the presence or
absence of 10% FBS for 72 h. After 72 h, cells were treated with 1 mg/ml
MTT for 4 h. The precipitated formazan was solubilized with DMSO,
and dye uptake was measured at 550 nm using a 96-well plate reader
(VERSAmax, Molecular Devices, USA). Viability, or dye intensity,
of cells exposed to hyperglycemic (50 mM glucose) condition was calcu-
lated as a percentage of normoglycemic (5 mM glucose) culture dye
intensity.
2.3. Preparation of mitochondrial and cytosolic fraction
Cells were harvested in lysis buﬀer (10 mM Tris, pH 7.5, 1 mM
EDTA, 0.25 M sucrose, 1 mM Na3VO4, 1 lg/ml leupeptin, and
1 mM PMSF). Cells were disrupted by three cycles of freezing in liquidblished by Elsevier B.V. All rights reserved.
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2312 H.S. Kim et al. / FEBS Letters 580 (2006) 2311–2316nitrogen and thawing, and these preparations were centrifuged at
1000 · g for 10 min at 4 C to remove unbroken cells and nuclei.
The supernatant was centrifuged at 15000 · g for 20 min at 4 C to ob-
tain the mitochondria-rich fraction (pellet). The pellet was resuspended
in lysis buﬀer (150 mM NaCl, 50 mM Tris–Cl, pH 7.4, 1% Nonidet P-
40, 0.25% sodium deoxycholate, 1 mM EGTA, 1 lg/ml leupeptin, and
1 mM PMSF). The supernatant was then centrifuged at 100000 · g for
30 min at 4 C to separate the microsomal (pellet) and cytosolic (super-
natant) fractions.
2.4. Immunoblotting
Proteins were separated by SDS–PAGE and transferred to nitrocel-
lulose membranes. The membrane was blocked with 5% non-fat milk
in Tris-buﬀered saline and incubated with primary antibodies over-
night at 4 C. Blots were developed using peroxidase-conjugated sec-
ondary antibodies and visualized with enhanced chemiluminescence
reagent (Amersham Biosciences, UK) according to the manufacturer’s
recommendations.
2.5. Immunoprecipitation
Proteins were incubated with antibodies directed against HSP60
(SPA-806, Stressgen, USA; H-300, Santa Cruz, USA), Bax (N-20,
Santa Cruz, USA), orO-GlcNAc (CTD 110.6, Covance Research Prod-
ucts, USA) overnight at 4 C followed by an additional 2-h incubation
with 50 ll of packed protein A-Sepharose or protein L-Sepharose
beads. The bound proteins were analyzed by immunoblotting with
speciﬁc antibodies for HSP60, Bax, or O-GlcNAc.48241260Time (hr)
β-actin
Fig. 1. Numerous proteins are modiﬁed with O-linked N-acetylglu-
cosamine (O-GlcNAc) in response to glucose. (A) Cells were treated
with the indicated concentrations of glucose for 48 h. (B) Cells were
treated with 50 mM glucose for the indicated times. Twenty micro-
grams of cell lysate was subjected to immunoblot analysis using an
anti-O-GlcNAc antibody (CTD110.6).2.6. Two-dimensional gel electrophoresis (2-DE)
Proteins were separated by 2-DE as described previously [13].
Protein extracts from cells treated with 5 or 50 mM glucose were
analyzed by 2-DE, which consisted of an initial isoelectric focusing
step (pH range of 3–10), followed by electrophoretic separation on a
10% gel, staining with Coomassie Brilliant Blue G250 (CBB), and
immunoblotting with speciﬁc antibodies. The stained gels were
scanned using the GS-800 Calibrated Densitometer (Bio-Rad,
USA) and analyzed using the Image Master (Geneva Bioinformat-
ics, Switzerland).
2.7. Matrix-assisted laser desorption/ionization (MALDI)-time-of-ﬂight
(TOF)-mass spectrometry (MS)
Protein spots of interest (representing O-GlcNAcylated proteins)
were excised from the gels, and reduction, alkylation, and in-gel diges-
tion were performed essentially as described previously [14]. MALDI
mass spectra of peptide mixtures were obtained using the 4700 Proteo-
mics Analyzer (Applied Biosystems, USA). To identify proteins, short
stretches of amino acid sequences interpreted fromMALDI mass spec-
tra were searched against the NCBI non-redundant database, using
MASCOT Peptide Mass Fingerprint software (http://www.matrix-
science.com) and ProFound search engines (http://prowl.rockefel-
ler.edu/profound_bin/WebProFound.exe). All complete or partial
sequences were compared with those of the proteins from a MASCOT
or BLAST similarity search (www.ncbi.nlm.nih.gov/BLAST) to obtain
the identiﬁcations with high conﬁdence.
2.8. Statistical analysis
Data are presented as mean ± S.E.M. and represent at least three
independent experiments. Comparisons of means were performed using
Student’s t test. Values of p 6 0.05 were accepted as signiﬁcant.3. Results and discussion
3.1. Identiﬁcation of O-GlcNAcylated proteins under
hyperglycemic conditions
The eﬀect of glucose on the levels of O-GlcNAcylated pro-
teins was examined using immunoblotting with an O-GlcNAc
speciﬁc antibody (CTD110.6). As shown in Fig. 1A, incubation
of cell cultured for 48 h with increasing concentrations of glu-
cose (5, 10, 20, and 50 mM) was associated with an increasedlevel of O-GlcNAcylated proteins. This eﬀect was most appar-
ent in response to 50 mM glucose and occurred at least 24 h
after glucose addition (Fig. 1B). To identify the proteins that
were modiﬁed by O-GlcNAc under hyperglycemic conditions,
2-DE was employed. Protein spots corresponding to immu-
no-detected proteins in three diﬀerent areas were excised from
the duplicate protein-stained gel (Fig. 2), and the peptides were
analyzed byMALDI-TOFMS (Table 1). Under hyperglycemic
conditions, the levels of O-GlcNAcylated ezrin, moesin, and
HSP60 were elevated, while the levels of O-GlcNAcylated gly-
cogen debranching enzyme and lamin A were decreased. Ezrin
and moesin are known to be O-GlcNAcylated [15]. Among the
heat shock protein family members, HSP70 and HSP90 have
been reported to beO-GlcNAcylated [10,16]. This is the ﬁrst re-
port of HSP60 being modiﬁed with O-GlcNAc.
3.2. O-GlcNAcylation of HSP60 is enhanced under
hyperglycemic conditions
That HSP60 was modiﬁed with O-GlcNAc under hypergly-
cemic conditions was conﬁrmed using immunoprecipitation/
immunoblotting. As shown in Fig. 3, while the total HSP60
protein levels did not change in response to hyperglycemic
conditions, O-GlcNAcylated HSP60 levels were increased by
221.3% (±3.6) relative to the normoglycemic control. O-Glc-
NAcylation and phosphorylation of serine/threonine residues
modulate one another, as described by the ‘‘ying-yang’’
model, and these post-translational modiﬁcations have
important consequences in protein activity and signaling
[17]. We investigated whether O-GlcNAcylation of HSP60
Fig. 2. Analysis of O-GlcNAcylated proteins using two-dimensional gel electrophoresis (2-DE). (A) Proteins from cells cultured under
normoglycemic (NG) or hyperglycemic (HG) conditions for 24 h were separated by 2-DE and analyzed by immunoblotting with an anti-O-GlcNAc
antibody (CTD110.6). (B) Proteins on analytical gels were visualized by Coomassie Brilliant Blue G250 (CBB) staining. Protein spots corresponding
to immuno-detected proteins in areas a, b, and c were excised from the gel for subsequent mass spectrometric analysis.
Table 1
The proteins altered in O-GlcNAcylation status during hyperglycemia
Spot # Gene code Description Pattern
a-1 NP_071565 Heat shock 60 kD
protein 1 (chaperonin)
Increase
b-1,2,3 AAL47844 Ezrin Increase
b-4,5 NP_110490 Moesin Increase
c-1 ZP_00211862 Glycogen debranching
enzyme
Decrease
c-2 P48679 Lamin A Decrease
Protein spots selected in areas a, b, and c of the gel shown in Fig. 2
were identiﬁed by MALDI-TOF mass spectrometry.
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sine residues under hyperglycemic conditions. We did not de-
tect any signiﬁcant diﬀerences in the phosphorylation
patterns of HSP60 under normoglycemic and hyperglycemic
conditions (data not shown).
3.3. Hyperglycemia is associated with decreased cell viability
and caspase-3 activation
Prolonged HG induces cell death, which may be a result of
the glucose toxicity, and promotes O-GlcNAcylation of pro-
teins both in vitro and in vivo [18,19]. However, a direct or
Fig. 3. O-GlcNAcylation of HSP60 is enhanced under hyperglycemic
conditions. (A) Total HSP60 levels in cells cultured under normogly-
cemic (NG) or hyperglycemic (HG) conditions for 24 h were deter-
mined by immunoblot analysis. All immunoblots were normalized to
b-actin. Total levels of HSP60 under HG conditions are expressed as a
percent of those found in the NG cultures. Data are presented as
mean ± S.E.M., and are from six independent experiments. (B)
Proteins were immunoprecipitated with an antibody against HSP60
or O-GlcNAc (CTD110.6), and the resulting immunoprecipitates were
subjected to immunoblot analysis using anti-HSP60 or O-GlcNAc
antibodies. The levels of HSP60 modiﬁed with O-GlcNAc under HG
conditions are expressed as a percent of those found in the NG
cultures. Data are presented as mean ± S.E.M., and are from three
independent experiments. *p 6 0.05 vs. NG conditions.
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Fig. 4. Hyperglycemia is associated with decreased cell viability and
caspase-3 activation. (A) Cell viability was determined using the MTT
assay as described in Section 2. Cell viability under hyperglycemic
conditions (HG) is expressed as a percent of the normoglycemic
control (NG). Results are presented as mean ± S.E.M. and represent
three independent experiments. *p 6 0.05 vs. NG conditions in the
presence of 10% FBS. (B) Caspase-3 activation was determined by
immunoblot analysis after treatment with 50 mM glucose for the
indicated times.
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cell death remains controversial [11]. Therefore, we examined
cell viability and caspase-3 activation in response to HG.
The percent viability of cells exposed to normoglycemic and
hyperglycemic conditions, in the absence of 10% FBS, was
77.48% (±3.33) and 65.57% (±2.08), respectively. The percent
viability of cell, in the presence of 10% FBS, was decreased
by 63.83% (±1.48) under hyperglycemic conditions relative to
the normoglycemic control (Fig. 4A). Importantly, HG-in-
duced decreases in cell viability were associated with caspase-
3 activation (Fig. 4B). These results suggest that the enhanced
O-GlcNAc levels observed in response to HG may be involved
in cell death.
3.4. Cytosolic HSP60–Bax interactions are reduced under
hyperglycemic conditions
A number of heat shock proteins alter their cellular distribu-
tion in response to stress and have complex roles during apop-
tosis, but are primarily thought to be anti-apoptotic [20,21].Modiﬁcation with O-GlcNAc may alter the regulation or
localization of heat shock proteins, including HSP70 [10].
HSP70 has been reported to be phosphorylated and O-GlcNA-
cylated, and O-GlcNAcylation could function in regulating
nucleo-cytoplasmic shuttling and in altering protein stability
[16,22]. HSP60, especially in the extra-mitochondrial cytosol,
has been shown to prevent death by interacting with Bax
[23,24]. Since O-GlcNAcylation of HSP60 was enhanced under
hyperglycemic conditions, we reasoned that elevated O-Glc-
NAcylation might modulate the anti-apoptotic actions of
HSP60. Under all conditions examined, HSP60 was found pre-
dominantly in mitochondrial fraction with small amounts in
the cytosolic fraction (Fig. 5A). We examined whether Bax
translocates from cytosol to mitochondria under hyperglyce-
mic conditions. Under hyperglycemic conditions, cytosolic
Bax levels were decreased, while mitochondrial Bax levels were
increased (twofold) (Fig. 5A and C). Moreover, cytosolic
Cyto c levels were increased, indicating that release from mito-
chondria had occurred (Fig. 5A). Although cytosolic HSP60
levels were the same under all conditions, immunoprecipita-
tion/immunoblotting analysis revealed a 206.2% (±11.2) in-
crease in cytosolic O-GlcNAcylated HSP60 levels under
hyperglycemic conditions relative to the normoglycemic con-
trol (Fig. 5B and D). Immunoprecipitation/immunoblotting
also revealed that the interactions between HSP60 and Bax
were decreased by 62.2% (±3.6) under hyperglycemic condi-
tions relative to the normoglycemic control (Fig. 5B and D).
Since Bax is a pro-apoptotic protein, these ﬁndings suggest
that HSP60 prevents apoptosis by sequestering Bax in the
cytoplasm. In summary, the present study provides evidence
that elevated O-GlcNAcylation of HSP60 prevents its binding
Fig. 5. Cytosolic HSP60–Bax complexes are reduced under hypergly-
cemic conditions. Cytosolic and mitochondrial fractions were obtained
from cells cultured under normoglycemic (NG) or hyperglycemic (HG)
conditions for 24 h as described in Section 2. (A) Immunoblot analysis
of cytosolic and mitochondrial fractions was performed using speciﬁc
antibodies for HSP60, Bax, or cytochrome c (Cyto c). (B) Cytosolic
proteins were immunoprecipitated using anti-HSP60 or Bax antibod-
ies, and the resulting immunoprecipitates were subjected to immuno-
blot analysis using anti-HSP60, Bax or O-GlcNAc antibodies. (C)
HSP60 and Bax levels in cytosolic or mitochondrial fractions were
determined by immunoblotting. All immunoblots were normalized to
b-actin. HSP60 and Bax levels under HG conditions are expressed as a
percentage of the levels found in NG cultures. (D) The proportion of
HSP60 modiﬁed with O-GlcNAc was determined by immunoprecip-
itation/ immunoblotting and is expressed as percentage of the levels
found under NG conditions. Levels of HSP60–Bax complexes were
determined by immunoprecipitation/immunoblot analysis. Levels of
HSP60–Bax complexes under HG conditions are expressed as a
percentage of complex levels present under NG conditions. Data are
presented as mean ± S.E.M. and represent three independent experi-
ments. *p 6 0.05 vs. NG conditions.
H.S. Kim et al. / FEBS Letters 580 (2006) 2311–2316 2315to Bax, resulting in Bax translocation to mitochondria, Cyto c
release, caspase-3 activation, and subsequent pancreatic b-cell
death.
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